Securian Asset Management Inc. Sells 292 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Securian Asset Management Inc. trimmed its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 2.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,622 shares of the medical device company’s stock after selling 292 shares during the quarter. Securian Asset Management Inc.’s holdings in Cooper Companies were worth $976,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. EverSource Wealth Advisors LLC raised its holdings in shares of Cooper Companies by 9.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 6,297 shares of the medical device company’s stock valued at $579,000 after buying an additional 518 shares during the last quarter. Wealthfront Advisers LLC increased its position in Cooper Companies by 4,594.1% in the fourth quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company’s stock worth $52,383,000 after purchasing an additional 557,673 shares during the period. Tortoise Investment Management LLC increased its position in Cooper Companies by 77.1% in the fourth quarter. Tortoise Investment Management LLC now owns 790 shares of the medical device company’s stock worth $73,000 after purchasing an additional 344 shares during the period. Daiwa Securities Group Inc. increased its position in Cooper Companies by 6.5% in the fourth quarter. Daiwa Securities Group Inc. now owns 33,894 shares of the medical device company’s stock worth $3,116,000 after purchasing an additional 2,083 shares during the period. Finally, AlphaQuest LLC increased its position in Cooper Companies by 2,137.2% in the fourth quarter. AlphaQuest LLC now owns 13,938 shares of the medical device company’s stock worth $1,281,000 after purchasing an additional 13,315 shares during the period. 24.39% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on COO shares. Piper Sandler reiterated an “overweight” rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus lowered their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. JPMorgan Chase & Co. decreased their target price on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Friday, March 7th. Finally, StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $111.89.

Cooper Companies Price Performance

Shares of COO opened at $81.22 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a 50 day simple moving average of $91.20 and a 200 day simple moving average of $98.90. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The firm has a market capitalization of $16.24 billion, a PE ratio of 41.65, a P/E/G ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.